Wang, L., Zhang, Y., He, Y., Li, J., Wang, T., Xie, Y., . . . Ouyang, T. (2021). Impact of dose-dense neoadjuvant chemotherapy on pathologic response and survival for HER2-positive breast cancer patients who receive trastuzumab. Nature Portfolio.
Style de citation Chicago (17e éd.)Wang, Lize, Yang Zhang, Yingjian He, Jinfeng Li, Tianfeng Wang, Yuntao Xie, Zhaoqing Fan, et Tao Ouyang. Impact of Dose-dense Neoadjuvant Chemotherapy on Pathologic Response and Survival for HER2-positive Breast Cancer Patients Who Receive Trastuzumab. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Wang, Lize, et al. Impact of Dose-dense Neoadjuvant Chemotherapy on Pathologic Response and Survival for HER2-positive Breast Cancer Patients Who Receive Trastuzumab. Nature Portfolio, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.